Basic Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102913
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102913
Figure 5
Figure 5 Comparison of chemotherapeutic effects in groups with high and low F-box protein 22 levels based on The Cancer Genome Atlas-colon adenocarcinoma cohort and analysed by R package oncoPredict. IC50 was calculated for tipifarnib. FBXO22: F-box protein 22.